Friday, October 16, 2009

Looking Back and Moving Forward in Philippine Medical Oncology

In celebration of the 40th year of the Philippine Society of Medical Oncology (PSMO), the group launched a series of seminars and lectures at the EDSA Shangri-la Hotel with the collective theme “Looking Back… Moving Forward.”

The convention was held for three days, from Oct. 7–9, and was composed of different specialized sessions and luncheon satellite symposia.

The opening ceremonies and the opening of the convention exhibits kicked off the first day, followed by the first luncheon satellite symposium (Hepatocellular Carcinoma: Current and Evolving Therapies), helmed by Dr. Bruno Daniele, Director of the Oncology Unit at the G. Rummo Hospital in Italy. This segment was sponsored by Bayer Philippines. The Annual Research Paper Contest was held in the afternoon. The special session for nurses was also held in the first day, with topics such as Principles of Pallative Care (Dr. Rhodora Ocampo), The Nursing Philosophy (RN Lydia Manahan), and Ethical Principles of End of Life Care (Dr. Victoria Edna Monzon).

The second day began with the Dr. Bernardo Agustin Memorial Lecture. The first session of the day was Targeted Therapies in Cancer by Prof. Fortunato Ciardellio of the Seconda Universita di Napoli in Naples, Italy. Other lectures included Advanced Renal Cell Carcinoma: Emerging Options and Future Directions (Prof. David Goldstein, Prince of Wales Hospital; sponsored by Novartis Healthcare); Evolution from Chemotherapy to Targeted Therapies in NSCLC (Prof. Caicun Zhou, Tongji University Medical School, sponsored by Roche Philippines); and Looking Back… Moving Forward from Germcitabine to Permetrexed in NSCLC (Prof. Johan Vansteenkiste, Catholic University of Leuven, sponsored by Eli Lilly Philippines). The second luncheon satellite symposium was conducted by Prof. Fortunato Ciardellio, with the topic Catuximab in Colorectal Cancer.

The third and final day of the lecture series began with Dr. Matthew Yap from Chong Hua Hospital and Cebu Doctors Hospital, with the topic Lymphomas: CHOP vs Promace Cytabom vs R-CHOP Trials. This session was followed by Small Cell Lung Cancer (SCLC): What’s New by Dr. Roselle De Guzman of St. Luke’s Medical Center and MCU Hospital. Other sessions that followed were Renal Cell Carcinoma by Dr. Jemela Anne Osorio-Sanchez from the Perpetual Succor Hospital; Hepatocellular Cancer by Dr. Eugenio Emmanuel Regala from University of Santo Tomas Hospital and Medical City; Nimotuzumab: Decoupling Efficacy and Safety (the third luncheon satellite symposium) by Dr. Anthony Brade from the Princess Margaret Hospital; Lymphadema Assessment After Breast Surgery by Dr. Brian Ziegelaar (sponsored by GenAsia Biotech); Cancer Associated Thrombosis: Evidence and Implications in Asian Cancer Patients by Dr. Pramook Mutirangura from the Siriraj Medical School, Mahindol University (sponsored by Leo Pharma); Pancreatic Cancer by Dr. Dennis Tudtud from the Perpetual Succor Hospital; and GIST by Dr. Adonis Guancia from the Riverside Medical Center.


Post a Comment